About Swiss Parenterals
Swiss Parenterals is a company based in Ahmedabad (India) founded in 1986 by Vikrambhai Rasiklal Shah was acquired by ERIs Life Sciences in February 2024. It operates as a Direct-to-Consumer (D2C) and Reseller / Distribution. Swiss Parenterals offers products and services including Sterile Injectables, Oral Solids, Semi-Solids, Nutritional Supplements, and Ayurvedic Products. Swiss Parenterals operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Ahmedabad, India
- Founders Vikrambhai Rasiklal Shah
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Swiss Parenterals
-
Annual Revenue
$38.52 M (USD)36as on Mar 31, 2024
-
Net Profit
$8.45 M (USD)18as on Mar 31, 2024
-
EBITDA
$12.87 M (USD)20as on Mar 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
ERIs Life Sciences
(Feb 13, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Swiss Parenterals
Swiss Parenterals offers a comprehensive portfolio of products and services, including Sterile Injectables, Oral Solids, Semi-Solids, Nutritional Supplements, and Ayurvedic Products.
Sterile injectables are manufactured for global market distribution.
Oral solids are produced for various health condition treatments.
Semi-solids are optimized for controlled injection in treatments.
Nutritional supplements are offered to boost immunity and energy.
Ayurvedic products are developed for physical and mental health.
People of Swiss Parenterals
Unlock access to complete
Funding Insights of Swiss Parenterals
Detailed funding history for Swiss Parenterals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Swiss Parenterals
Swiss Parenterals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include ERIs Life Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical formulations for chronic diseases are manufactured and studied.
|
Locked | Locked | Locked |
Investor details for Swiss Parenterals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Swiss Parenterals
Investment portfolio details for Swiss Parenterals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Swiss Parenterals
Detailed financials for Swiss Parenterals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Swiss Parenterals Comparisons
Peer comparison for Swiss Parenterals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Swiss Parenterals
Swiss Parenterals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Swiss Parenterals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Swiss Parenterals
Complete news archive for Swiss Parenterals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swiss Parenterals
Swiss Parenterals was founded in 1986.
Swiss Parenterals is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Piyush Pandya is the current CEO of Swiss Parenterals.
Annual revenue of Swiss Parenterals is $38.52M as on Mar 31, 2024.
Swiss Parenterals is involved in the development and manufacturing of sterile injectables, oral solids, semi-solids, and nutritional supplements for global markets. The company operates in over 80 countries, focusing on generic and specialty pharmaceuticals. Its services include product development, analytical support, and regulatory assistance at cGMP-compliant facilities. Approvals from EU-GMP, Brazilian ANVISA, and other international bodies are held by the company. A wide range of dosage forms, including complex formulations, are produced across three manufacturing units in Ahmedabad, India. Veterinary and Ayurvedic products are also offered to cater to diverse health needs.
Swiss Parenterals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Swiss Parenterals offers Sterile Injectables, Oral Solids, Semi-Solids, Nutritional Supplements, and Ayurvedic Products.
Swiss Parenterals has 1 investor. Key investors include ERIs Life Sciences.